Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Intiland, Kalbe Farma, Panorama: Indonesian Equity Preview

Don't Miss Out —
Follow us on:

April 19 (Bloomberg) -- Shares of the following companies may have unusual moves in Indonesian trading. Stock symbols are in parentheses, and share prices are as of the previous close.

The Jakarta Composite index rose 0.2 percent to 4,166.24.

PT Intiland Development (DILD IJ): The property developer is seeking a bank loan of about 840 billion rupiah ($92 million) to help fund this year’s capital expenditure of as much as 1.4 trillion rupiah, Investor Daily Indonesia reported, citing Corporate Secretary Theresia Rustandi. Intiland fell 2.6 percent to 380 rupiah.

PT Kalbe Farma (KLBF IJ): Indonesia’s biggest drug company expects first-quarter sales to have risen 15 percent to 20 percent to as much as 2.7 trillion rupiah as it expanded its distribution network and introduced new products, Investor Daily Indonesia reported, citing Director Vidjongtius. Kalbe Farma was unchanged at 3,450 rupiah.

PT Panorama Transportasi (WEHA IJ): The taxi and tourism bus operator added 200 premium-class taxis, bringing its total transportation fleet to more than 1,000 units, Kontan reported, citing Budi Tirtawisata, chief executive officer of the Panorama Group. Panorama Transportasi climbed 0.6 percent to 157 rupiah.

To contact the reporter on this story: Berni Moestafa in Jakarta at

To contact the editor responsible for this story: Darren Boey at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.